APA

Chang K., Tsai S., Wu C., Yen C., Chuang B. & Chang J. (20120325). Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Chang Kwang-Yu, Tsai Shan-Yin, Wu Ching-Ming, Yen Chia-Jui, Chuang Bin-Fay and Chang Jang-Yang. 20120325. Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Chang K., Tsai S., Wu C., Yen C., Chuang B. and Chang J. (20120325). Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Chang Kwang-Yu, Tsai Shan-Yin, Wu Ching-Ming, Yen Chia-Jui, Chuang Bin-Fay and Chang Jang-Yang. Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20120325.